Coprescription of QT interval-prolonging antipsychotics with potentially interacting medications in Thailand

BACKGROUND: The US FDA has designated pimozide, thioridazine, and ziprasidone as contraindicated for patients at risk of QT interval prolongation, and assigned haloperidol, olanzapine, paliperidone, quetiapine, and risperidone as associated with a significant risk of QT prolongation. This study aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Waleekhachonloet, Onanong, Limwattananon, Chulaporn, Rattanachotphanit, Thananan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566479/
https://www.ncbi.nlm.nih.gov/pubmed/31223470
http://dx.doi.org/10.1177/2042098619854886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566479/
https://www.ncbi.nlm.nih.gov/pubmed/31223470
http://dx.doi.org/10.1177/2042098619854886

Ejemplares similares